Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood

Autor: Candice Z. Ulmer, Niklas Rye Jørgensen, Richard Eastell, Konstantinos Makris, Annemieke C. Heijboer, Harjit Pal Bhattoa, Etienne Cavalier, Cyrus Cooper, Samuel Vasikaran, Stuart L. Silverman, John A. Kanis
Přispěvatelé: Laboratory for Endocrinology, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Clinical chemistry, Amsterdam Gastroenterology Endocrinology Metabolism, Amsterdam Reproduction & Development (AR&D)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Clinica chimica acta; international journal of clinical chemistry, 515, 16-20. Elsevier
Bhattoa, H P, Cavalier, E, Eastell, R, Heijboer, A C, Jørgensen, N R, Makris, K, Ulmer, C Z, Kanis, J A, Cooper, C, Silverman, S L & Vasikaran, S D 2021, ' Analytical considerations and plans to standardize or harmonize assays for the reference bone turnover markers PINP and β-CTX in blood ', Clinica Chimica Acta, vol. 515, pp. 16-20 . https://doi.org/10.1016/j.cca.2020.12.023
Clin Chim Acta
Clinica Chimica Acta, 515, 16-20. Elsevier
ISSN: 0009-8981
DOI: 10.1016/j.cca.2020.12.023
Popis: Procollagen type I N-propeptide (PINP) and the C-terminal telopeptide of type I collagen (β-CTX) in blood have been designated as reference bone turnover markers in osteoporosis by the International Osteoporosis Foundation (IOF) and International Federation of Clinical Chemistry and Laboratory Medicine (IFCC). The IFCC Committee on Bone Metabolism (C-BM) has examined current commercial assays and performed a multicentre study to examine the agreement between assays for PINP and β-CTX in serum and plasma. The results of these studies will inform our work towards the harmonization of PINP assays and the standardization of β-CTX assays in blood, with the development of common calibrators and reference measurement procedures in collaboration with the reagent manufacturing industry. Successful achievement of these goals will help develop universally acceptable practice guidelines for the management of osteoporosis with the inclusion of common reference intervals and treatment targets for PINP and β-CTX.
Databáze: OpenAIRE